Medical Holographic Imaging Market: Top Companies & Insights

By /

Medical Holographic Imaging Market Companies

  • EchoPixel, Inc.
  • RealView Imaging Ltd.
  • Ovizio Imaging Systems NV/SA
  • Holoxica Ltd.
  • ZSpace, Inc.
  • Lyncee Tec SA
  • Zebra Imaging, Inc.
  • Leia Inc.
  • Holografika Kft.
  • NanoLive SA
  • VividQ Ltd.
  • Lightspace Technologies
  • Mach7 Technologies
  • Microsoft Corporation
  • Qualcomm Technologies, Inc.

Get Sample Report

EchoPixel, Inc.

  • Company Name and Headquarters: EchoPixel, Inc. (Santa Clara, California, USA)

  • Product Offerings Related to Medical Holographic Imaging: EchoPixel’s flagship product is True3D Viewer, a proprietary interactive virtual reality software that transforms standard medical images (CT, MRI, ultrasound) into realistic, dynamic 3D holographic visualizations. It allows clinicians to interact with patient anatomy in an open-air 3D space, facilitating pre-operative planning, intraoperative guidance, and medical education. They also offer a suite of procedural applications for specific clinical areas like cardiology and radiology.

  • Market Share and Estimated Revenue from Medical Holographic Imaging Segment: EchoPixel is a significant player in the clinical interactive holographic visualization space. While specific revenue figures are not public, they are considered a leader in providing actionable holographic solutions for surgical planning and intervention. Their revenue is primarily driven by software licenses and subscriptions.

  • Recent Developments, Partnerships, or Innovations:

    • Continuous expansion of clinical applications (e.g., structural heart disease, complex oncology cases).

    • Partnerships with major medical device companies and healthcare systems to integrate True3D into existing workflows.

    • Innovations in AI and machine learning to enhance image segmentation and 3D rendering.

    • Focus on FDA clearances for new clinical indications.

  • Competitive Positioning and Strategic Focus: EchoPixel is strategically positioned as a pioneer and leader in interactive, mixed-reality holographic imaging for clinical use. Their focus is on improving procedural outcomes and diagnostic accuracy through intuitive 3D visualization. They differentiate themselves through ease of integration with existing PACS systems and a strong clinical validation pipeline.

  • Key Customers or Industries Served: Hospitals, academic medical centers, radiology departments, cardiology departments, surgical suites, medical device companies (for training and planning), and medical education institutions.

RealView Imaging Ltd.

  • Company Name and Headquarters: RealView Imaging Ltd. (Yokneam Ilit, Israel)

  • Product Offerings Related to Medical Holographic Imaging: RealView Imaging develops and markets a volumetric display system that projects realistic, dynamic 3D holographic images “in the air,” allowing for true spatial interaction without the need for special eyewear. Their primary offering, Medical Holography System, integrates with medical imaging modalities to provide surgeons and interventionalists with real-time, touchless 3D holographic visualization of patient anatomy during procedures.

  • Market Share and Estimated Revenue from Medical Holographic Imaging Segment: RealView is a niche but highly innovative player in the true volumetric holographic display market. While market share is small compared to overall medical imaging, they are a leader in this specific “in-air” holographic interaction segment. Revenue is primarily from system sales and associated software.

  • Recent Developments, Partnerships, or Innovations:

    • Significant partnerships with major medical device companies (e.g., Philips Healthcare for cardiac interventions).

    • Continued refinement of their “in-air” display technology for improved resolution and interactivity.

    • Expansion of clinical trials and applications, particularly in cardiology, structural heart, and oncology.

    • Focus on real-time integration with live imaging sources (e.g., fluoroscopy, ultrasound).

  • Competitive Positioning and Strategic Focus: RealView’s unique selling proposition is its ability to project genuine volumetric holograms that can be manipulated in free space, offering an unparalleled level of immersion and intuitive interaction for interventional procedures. Their strategic focus is on revolutionizing procedural guidance by providing real-time, hands-free 3D visualization.

  • Key Customers or Industries Served: Interventional cardiologists, electrophysiologists, interventional radiologists, surgeons, and medical research institutions.

Ovizio Imaging Systems NV/SA

  • Company Name and Headquarters: Ovizio Imaging Systems NV/SA (Gosselies, Belgium)

  • Product Offerings Related to Medical Holographic Imaging: Ovizio specializes in quantitative live cell imaging using differential digital holographic microscopy (DDHM). Their iLine series of microscopes and imaging systems leverage holographic principles to provide high-resolution, label-free, and non-invasive imaging and analysis of cells in real-time, directly within bioreactors or culture flasks. This includes cell counting, viability, morphology, and differentiation monitoring.

  • Market Share and Estimated Revenue from Medical Holographic Imaging Segment: Ovizio is a key player in the niche but growing field of label-free holographic cell imaging for bioprocessing and research. While not a direct competitor in macroscopic medical holographic displays, they are significant in microscopic applications. Revenue is from instrument sales, software, and consumables.

  • Recent Developments, Partnerships, or Innovations:

    • Development of advanced AI-powered image analysis software for automated cell characterization.

    • Expansion into new applications such as gene therapy manufacturing, stem cell research, and vaccine production.

    • Partnerships with biopharmaceutical companies and research organizations for process analytical technology (PAT) integration.

    • Innovations in making holographic microscopy more robust and user-friendly for industrial settings.

  • Competitive Positioning and Strategic Focus: Ovizio’s competitive edge lies in its unique DDHM technology, which enables high-throughput, non-invasive, and label-free monitoring of live cells. Their strategic focus is on empowering biopharmaceutical companies and researchers with real-time, quantitative insights into cell culture processes, reducing development time and improving product quality.

  • Key Customers or Industries Served: Biopharmaceutical companies, cell therapy manufacturers, vaccine producers, academic research institutions, biotech startups, and contract manufacturing organizations (CMOs).

Holoxica Ltd.

  • Company Name and Headquarters: Holoxica Ltd. (Edinburgh, Scotland, UK)

  • Product Offerings Related to Medical Holographic Imaging: Holoxica is focused on the research and development of dynamic 3D holographic displays for various applications, including medical. While not yet a widely commercialized product for clinical use, their technology aims to create true 3D volumetric images that can be viewed from multiple angles without glasses. They have demonstrated prototypes capable of displaying medical CT and MRI scans in dynamic, full-color holograms.

  • Market Share and Estimated Revenue from Medical Holographic Imaging Segment: Holoxica is primarily an R&D-focused company. As such, they do not hold significant market share or generate substantial direct revenue from commercial medical holographic imaging products yet. Their revenue comes from R&D contracts, grants, and technology licensing.

  • Recent Developments, Partnerships, or Innovations:

    • Development of custom high-speed spatial light modulators (SLMs) for dynamic hologram generation.

    • Ongoing research in electro-holography and computational holography to improve image quality and display size.

    • Participation in academic and industry consortiums exploring next-generation 3D displays.

    • Focus on developing a scalable and cost-effective true 3D holographic display technology.

  • Competitive Positioning and Strategic Focus: Holoxica’s competitive position is in the cutting-edge development of true dynamic volumetric holographic displays, which represent the “holy grail” of 3D visualization. Their strategic focus is on perfecting this fundamental display technology, with medical imaging being a prime target application due to the need for precise 3D data interpretation.

  • Key Customers or Industries Served: Primarily research institutions, government defense agencies, and potential technology licensees in medical imaging, automotive, and entertainment sectors.

ZSpace, Inc.

  • Company Name and Headquarters: zSpace, Inc. (San Jose, California, USA)

  • Product Offerings Related to Medical Holographic Imaging: zSpace offers an interactive, immersive platform that combines augmented reality (AR) and virtual reality (VR) to create realistic 3D holographic experiences. While broadly applicable, their medical offerings include applications for medical education, surgical planning, and anatomical visualization. Their core product is a specialized laptop or all-in-one system with a stereoscopic display that, when combined with tracking eyewear and a stylus, allows users to interact with virtual 3D models as if they were real objects in space.

  • Market Share and Estimated Revenue from Medical Holographic Imaging Segment: zSpace is a recognized leader in AR/VR platforms for education, with a growing presence in medical education and training. While not strictly “holographic” in the true volumetric sense, their interactive stereoscopic 3D experiences are often referred to as holographic by users. Revenue is from system sales, software licenses, and content development.

  • Recent Developments, Partnerships, or Innovations:

    • Expansion of their medical content library, including detailed anatomical models and simulated surgical procedures.

    • Partnerships with medical schools and universities to integrate zSpace into their curriculum.

    • Continuous improvement of their display technology and tracking systems for enhanced immersion.

    • Focus on developing collaborative AR/VR experiences for multiple users.

  • Competitive Positioning and Strategic Focus: zSpace differentiates itself through its integrated hardware/software platform designed for intuitive 3D interaction and its strong focus on educational content. Their strategic focus in medical is to provide an accessible and effective platform for immersive learning and procedural rehearsal, improving student comprehension and clinical readiness.

  • Key Customers or Industries Served: Medical schools, nursing schools, anatomy departments, hospitals (for training), and medical device companies (for product demonstrations and training).

Lyncee Tec SA

  • Company Name and Headquarters: Lyncée Tec SA (Lausanne, Switzerland)

  • Product Offerings Related to Medical Holographic Imaging: Lyncée Tec specializes in digital holographic microscopy (DHM). Their DH-M series of microscopes provide label-free, quantitative phase imaging of biological samples. This technology allows for real-time, non-invasive observation of cell dynamics, morphology, and intracellular changes, which has significant applications in cell biology, toxicology, and drug discovery, including potential for medical diagnostics and research.

  • Market Share and Estimated Revenue from Medical Holographic Imaging Segment: Lyncée Tec is a prominent player in the scientific instrumentation market for digital holographic microscopy. Their market share is within this specialized segment, not the broader medical holographic display market. Revenue comes from sales of their DHM systems and associated software.

  • Recent Developments, Partnerships, or Innovations:

    • Development of advanced software algorithms for quantitative analysis of holographic images (e.g., cell tracking, dry mass measurement).

    • Expansion of applications in areas like neuroscience, microbiology, and in vitro fertilization (IVF).

    • Collaborations with research institutions and pharmaceutical companies to integrate DHM into new workflows.

    • Innovations in high-speed and multi-modal DHM systems.

  • Competitive Positioning and Strategic Focus: Lyncée Tec’s competitive advantage is its precise and reliable quantitative phase imaging capabilities, providing detailed insights into biological processes without the need for labeling. Their strategic focus is on providing cutting-edge holographic microscopy solutions that advance biological research and drug development.

  • Key Customers or Industries Served: Academic research laboratories, pharmaceutical companies, biotech companies, IVF clinics, and contract research organizations (CROs).

Zebra Imaging, Inc.

  • Company Name and Headquarters: Zebra Imaging, Inc. (Austin, Texas, USA)

  • Product Offerings Related to Medical Holographic Imaging: Zebra Imaging historically focused on producing large-format, static 3D holographic prints. These full-color, full-parallax holograms were created from 3D digital data and could display complex information, including medical imagery (e.g., CT, MRI scans) in a truly 3D, glasses-free format. While their primary market was defense and engineering, their technology had direct applications for medical visualization and education. Note: Zebra Imaging appears to be less active or to have pivoted significantly since 2017-2018; information below reflects their historical relevance in static holography.

  • Market Share and Estimated Revenue from Medical Holographic Imaging Segment: Historically, Zebra Imaging was a leader in the niche market of large-format static holographic prints. Their market share in dynamic medical holographic imaging was negligible. Revenue came from print sales and related services.

  • Recent Developments, Partnerships, or Innovations: Information on recent developments specifically for medical holographic imaging is limited. Their focus shifted heavily towards defense and specialized visualization.

  • Competitive Positioning and Strategic Focus: Zebra Imaging’s unique offering was the ability to produce high-resolution, full-parallax static holograms that could be viewed from any angle. Their strategic focus was on providing superior 3D visualization for complex data sets, including medical.

  • Key Customers or Industries Served: US Department of Defense, intelligence agencies, engineering firms, architectural firms, and historically, some medical education and planning groups.

Leia Inc.

  • Company Name and Headquarters: Leia Inc. (Menlo Park, California, USA)

  • Product Offerings Related to Medical Holographic Imaging: Leia Inc. develops lightfield display technology that creates a truly 3D, glasses-free viewing experience. Their displays project multiple perspectives of an image, allowing viewers to see 3D depth and parallax as they move their heads. While not “holographic” in the strict interference pattern sense, lightfield displays achieve a similar visual effect of a solid 3D object in space. Their technology is integrated into various devices, including tablets and monitors, with potential for medical visualization and education to provide glasses-free 3D medical images.

  • Market Share and Estimated Revenue from Medical Holographic Imaging Segment: Leia is a significant player in the lightfield display market, primarily targeting consumer electronics and automotive. Their market share in dedicated medical holographic imaging is currently nascent, but their technology has strong potential. Revenue comes from licensing their display technology and product sales.

  • Recent Developments, Partnerships, or Innovations:

    • Launch of Lume Pad 2, an improved lightfield tablet.

    • Partnerships with automotive companies for in-car 3D displays.

    • Development of a robust content ecosystem (Leia Appstore) to facilitate 3D content creation and consumption.

    • Innovations in display size, resolution, and viewing angles for their lightfield technology.

  • Competitive Positioning and Strategic Focus: Leia’s competitive advantage is its advanced lightfield display technology that offers glasses-free 3D viewing, making complex 3D data more accessible. Their strategic focus is on democratizing 3D visualization across various industries, including the potential for medical applications where intuitive 3D perception is crucial.

  • Key Customers or Industries Served: Consumer electronics manufacturers, automotive industry, developers of 3D content, and potentially medical device companies or education institutions seeking glasses-free 3D displays.

Holografika Kft.

  • Company Name and Headquarters: Holografika Kft. (Budapest, Hungary)

  • Product Offerings Related to Medical Holographic Imaging: Holografika is a pioneer in developing true holographic 3D displays. Their Holovizio series of displays generate genuine full-parallax, full-color 3D images that can be viewed without glasses, offering a true volumetric representation of digital data. This technology is highly relevant for medical imaging, enabling surgeons and diagnosticians to perceive medical scans (CT, MRI) in their actual 3D form, which aids in complex diagnoses and surgical planning.

  • Market Share and Estimated Revenue from Medical Holographic Imaging Segment: Holografika operates in a highly specialized, cutting-edge segment of true holographic displays. Their market share is small but significant within this niche. Revenue is from system sales and R&D projects.

  • Recent Developments, Partnerships, or Innovations:

    • Continuous improvement of their display technology to increase resolution, size, and viewing angles.

    • Participation in EU-funded research projects focused on advanced 3D visualization.

    • Demonstrations of their technology for medical and industrial applications.

    • Focus on computational efficiency for real-time holographic rendering.

  • Competitive Positioning and Strategic Focus: Holografika’s primary competitive advantage is its ability to produce truly volumetric, glasses-free holographic displays that avoid the visual artifacts of stereoscopic 3D. Their strategic focus is on delivering the most accurate and natural 3D visualization experience for professional applications where depth perception is critical, such as medical and design.

  • Key Customers or Industries Served: Medical research institutions, automotive design, scientific visualization, defense, and potentially medical device manufacturers.

NanoLive SA

  • Company Name and Headquarters: Nanolive SA (Tolochenaz, Switzerland)

  • Product Offerings Related to Medical Holographic Imaging: NanoLive manufactures and sells the 3D Cell Explorer, a live cell microscope that uses digital holographic tomography. This technology provides high-resolution, label-free 3D tomographic images of living cells, allowing researchers to visualize organelles and cellular processes in real-time and in 3D without causing phototoxicity. It’s used for various medical research applications, including drug discovery, toxicology, and cell biology.

  • Market Share and Estimated Revenue from Medical Holographic Imaging Segment: NanoLive is a key player in the specialized field of holographic tomography for live cell imaging. Their market share is within this microscopic research segment. Revenue is from instrument sales, software, and consumables.

  • Recent Developments, Partnerships, or Innovations:

    • Development of advanced software for AI-powered cell segmentation and quantitative analysis.

    • Expansion of applications into fields like immunology, neuroscience, and stem cell research.

    • Collaborations with leading research institutions to push the boundaries of live cell imaging.

    • Innovations in making their holographic microscopes more accessible and user-friendly for routine lab work.

  • Competitive Positioning and Strategic Focus: NanoLive’s competitive edge is its unique ability to provide truly label-free, high-resolution 3D images of live cells over extended periods, offering unprecedented insights into cellular dynamics. Their strategic focus is on advancing biological and medical research by providing innovative tools for non-invasive, quantitative live cell analysis.

  • Key Customers or Industries Served: Academic research institutions, pharmaceutical companies, biotech companies, contract research organizations (CROs), and university core facilities.

VividQ Ltd.

  • Company Name and Headquarters: VividQ Ltd. (Cambridge, UK)

  • Product Offerings Related to Medical Holographic Imaging: VividQ is a deep tech company specializing in computational holography software and intellectual property. They develop advanced algorithms that enable the real-time generation of complex 3D holographic images for displays. Their technology can be integrated into various hardware platforms to create true volumetric holographic displays. While not selling end-user medical devices, their software is crucial for powering next-generation holographic displays with applications in medical visualization, AR/VR, and automotive.

  • Market Share and Estimated Revenue from Medical Holographic Imaging Segment: VividQ is primarily a technology enabler; they don’t have direct market share in medical holographic devices but are a critical intellectual property provider. Revenue comes from licensing their software and IP to hardware manufacturers.

  • Recent Developments, Partnerships, or Innovations:

    • Development of highly optimized holographic rendering pipelines for various display technologies.

    • Partnerships with global tech companies in AR/VR and display manufacturing sectors.

    • Innovations in reducing computational load for real-time holographic video.

    • Expansion of their IP portfolio in computational holography.

  • Competitive Positioning and Strategic Focus: VividQ’s competitive advantage lies in its specialized expertise and proprietary algorithms for efficiently generating dynamic digital holograms. Their strategic focus is on being the leading provider of software and IP that unlocks the potential of true holographic displays across multiple industries, including medical imaging.

  • Key Customers or Industries Served: Display manufacturers, AR/VR headset developers, automotive companies, and potentially medical display system integrators and device manufacturers.

Lightspace Technologies

  • Company Name and Headquarters: Lightspace Technologies (Riga, Latvia)

  • Product Offerings Related to Medical Holographic Imaging: Lightspace Technologies develops multi-focal plane volumetric 3D displays. These displays rapidly project images onto multiple depth planes, creating the perception of a true volumetric 3D object that can be viewed without glasses and without vergence-accommodation conflict. Their technology has strong potential for medical applications, allowing clinicians to view medical scans (CT, MRI) in a truly spatial and interactive 3D format, enhancing diagnostic accuracy and surgical planning.

  • Market Share and Estimated Revenue from Medical Holographic Imaging Segment: Lightspace Technologies is a niche player in the volumetric display market, with a focus on specialized professional applications. Their market share in medical is currently small but growing as the technology matures. Revenue comes from system sales and R&D contracts.

  • Recent Developments, Partnerships, or Innovations:

    • Development of high-resolution, multi-focal plane displays for professional applications.

    • Participation in advanced visualization research projects.

    • Focus on improving display brightness, color accuracy, and interaction capabilities.

    • Exploration of new applications in medical simulation and data visualization.

  • Competitive Positioning and Strategic Focus: Lightspace Technologies differentiates itself by offering true volumetric perception without the typical issues of stereoscopic 3D (like eye strain). Their strategic focus is on providing superior 3D visualization solutions for demanding applications where precise depth perception and natural viewing are essential, making them a strong candidate for medical integration.

  • Key Customers or Industries Served: Medical research, defense, air traffic control, oil & gas exploration, scientific visualization, and potentially medical device companies.

Mach7 Technologies

  • Company Name and Headquarters: Mach7 Technologies (South Burlington, Vermont, USA – Global company with operations in Australia and US)

  • Product Offerings Related to Medical Holographic Imaging: Mach7 Technologies is a leading provider of enterprise imaging platforms, including Vendor Neutral Archives (VNA), Universal Viewers, and workflow orchestration solutions. While they don’t manufacture holographic displays, their platform is crucial for the efficient management, storage, and distribution of the large medical imaging datasets (CT, MRI, X-ray, etc.) that would feed into any holographic imaging system. Their universal viewer can display 2D and 3D reconstructed images, and their VNA ensures these images are accessible for advanced visualization tools, including potential holographic viewers.

  • Market Share and Estimated Revenue from Medical Holographic Imaging Segment: Mach7 holds a significant market share in the broader enterprise imaging and VNA market. They do not directly generate revenue from “holographic imaging” products but are a critical enabler for any advanced visualization, including holographic, by providing the data infrastructure.

  • Recent Developments, Partnerships, or Innovations:

    • Continuous enhancement of their enterprise imaging platform for scalability, interoperability, and AI integration.

    • Strategic partnerships with healthcare providers and other medical technology vendors.

    • Focus on cloud-native solutions and improved image sharing capabilities.

    • Acquisitions to expand their product portfolio and market reach (e.g., Client Outlook for its eUnity universal viewer).

  • Competitive Positioning and Strategic Focus: Mach7 is strategically positioned as a robust and flexible enterprise imaging backbone. Their focus is on enabling healthcare organizations to manage, share, and utilize their imaging data effectively, which is foundational for adopting advanced visualization technologies like medical holography. They differentiate with their open architecture and comprehensive VNA capabilities.

  • Key Customers or Industries Served: Hospitals, integrated delivery networks (IDNs), outpatient imaging centers, radiology groups, and teleradiology providers globally.

Microsoft Corporation

  • Company Name and Headquarters: Microsoft Corporation (Redmond, Washington, USA)

  • Product Offerings Related to Medical Holographic Imaging: Microsoft’s primary offering relevant to medical holographic imaging is the HoloLens, a mixed-reality headset. HoloLens overlays digital information and 3D holograms onto the real world, allowing users to interact with virtual objects in their physical environment. In medicine, HoloLens is used for:

    • Surgical Planning & Guidance: Overlaying 3D anatomical models (from CT/MRI) directly onto a patient during surgery.

    • Medical Education & Training: Immersive anatomical studies, simulated procedures.

    • Remote Collaboration: Tele-mentoring for surgeons and healthcare professionals.

    • Diagnostic Visualization: Viewing 3D medical images in a spatially aware manner.

  • Market Share and Estimated Revenue from Medical Holographic Imaging Segment: Microsoft is a dominant player in the broader mixed-reality headset market with HoloLens. While precise medical segment revenue isn’t public, they have a strong and growing presence in this area. Their revenue comes from HoloLens device sales, Azure cloud services supporting AR/VR, and software development kits.

  • Recent Developments, Partnerships, or Innovations:

    • Launch of HoloLens 2 with improved optics, field of view, and gesture tracking.

    • Development of Azure Mixed Reality services for cloud-powered AR applications.

    • Numerous partnerships with medical institutions (e.g., Case Western Reserve University) and medical device companies (e.g., Philips).

    • Innovations in AI and computer vision for better holographic rendering and interaction.

  • Competitive Positioning and Strategic Focus: Microsoft’s competitive strength lies in its comprehensive ecosystem (hardware, software, cloud services) and its brand recognition. Their strategic focus in medical is to leverage mixed reality to enhance clinical workflows, improve patient outcomes, and transform medical education through immersive, interactive 3D holographic experiences.

  • Key Customers or Industries Served: Hospitals, surgical departments, academic medical centers, medical device companies (for training and product development), medical education institutions, and pharmaceutical companies.

Qualcomm Technologies, Inc.

  • Company Name and Headquarters: Qualcomm Technologies, Inc. (San Diego, California, USA)

  • Product Offerings Related to Medical Holographic Imaging: Qualcomm is a leading developer of semiconductor and wireless technologies, including Snapdragon processors that power many AR/VR/XR devices, including next-generation holographic headsets. While they don’t produce end-user holographic devices, their chips are crucial components, providing the computational power, connectivity, and AI capabilities necessary for rendering complex 3D holograms in real-time. They also provide platforms like the Snapdragon XR Platform specifically designed for extended reality devices.

  • Market Share and Estimated Revenue from Medical Holographic Imaging Segment: Qualcomm is a dominant force in the mobile and XR processor market. While they don’t have direct revenue from “medical holographic imaging,” their processors are foundational to the hardware that enables it. Their revenue comes from chip sales and technology licensing.

  • Recent Developments, Partnerships, or Innovations:

    • Introduction of new Snapdragon XR platforms with enhanced performance, power efficiency, and AI accelerators.

    • Strategic partnerships with AR/VR/Holographic device manufacturers globally.

    • Investments in foundational research for spatial computing and perception.

    • Development of reference designs and software development kits to accelerate device development.

  • Competitive Positioning and Strategic Focus: Qualcomm’s competitive advantage is its leadership in high-performance, low-power processing and connectivity for mobile and XR devices. Their strategic focus is on being the enabling technology provider for the next wave of immersive computing, including holographic and mixed reality applications in healthcare.

  • Key Customers or Industries Served: AR/VR/XR device manufacturers, smartphone manufacturers, automotive industry, and indirectly, all industries adopting these advanced computing platforms, including medical device companies and healthcare providers.

Contact Us

Related Posts

Scroll to Top